Hybrid Event | 15th Annual
2027 Host Cell Protein Conference
Brussels, Belgium | 24-26 May 2027
About This Conference
More info coming soon!















What Your
Ticket Unlocks
Podium Presentations
Hear directly from industry experts and scientific leaders as they share the latest research, real-world insights, and emerging best practices shaping biopharmaceutical development.
Education Sessions
Go beyond listening and get hands-on with practical, interactive sessions designed to tackle challenges, explore new approaches, and bring ideas back to your team.
Connection Opportunities
Connect with scientists, industry experts, and peers through purposeful networking opportunities designed to spark conversations, share ideas, and build lasting connections.
Important
Dates
Pricing
Next Price Increase:
December 4, 2026
Registration Closes:
May 21, 2027
Abstracts
Podium Abstract Due:
November 13, 2026
Poster Abstract Due:
April 9, 2027
Final Files
Slides Due:
May 12, 2027
Poster File Due:
May 12, 2027
Draft Agenda
Our Hybrid 2027 Host Cell Protein Conference agenda is coming soon! Abstracts are due by November 13, 2026 to be considered for a podium talk. Check the agenda for updates as we finalize our schedule.
Participating Companies:
- List coming soon!
Registration Early Bird Prices:Prices increase end-of-day September 4, 2026.
Industry
-
Education Sessions
-
Podium Presentations
-
Networking Reception
Academic/Non-Profit
-
Education Sessions
-
Podium Presentations
-
Networking Reception
Independent Consultant
-
Education Sessions
-
Podium Presentations
-
Networking Reception
Government/Health Authority
-
Education Sessions
-
Podium Presentations
-
Networking Reception
Virtual
-
Podium Presentations
Group Discounts (only applicable to Industry tickets):
Hotel Information
Room block information coming soon!
nhow Brussels Bloom Hotel
Rue Royale 250,
1210 Bruxelles, Belgium
Telephone: +32 2 220 66 11
Website: nhow Brussels Bloom
2027 HCP Exhibitors
2027 Planning Committee
Lisette Coye
Coye CMC Strategies
Frieder Kröner
Novartis
John Maddalena
Medexus
Veronika Reisinger
Novartis
Florian Semmelmann
Roche
Kevin Van Cott
University of Nebraska – Lincoln
Fengqiang Wang
Merck & Co., Inc.
Ying Zhang
Eli Lilly and Company